ZURICH & MELBOURNE, Australia--(BUSINESS WIRE)--VUCCC P/L is pleased to announce that it has filed for patent protection of its ground breaking new treatment regimen for Type 1 ‘insulin-dependent’ diabetes, through the European Patent Office.
ZURICH & MELBOURNE, Australia--(BUSINESS WIRE)--VUCCC P/L is pleased to announce that it has filed for patent protection of its ground breaking new treatment regimen for Type 1 ‘insulin-dependent’ diabetes, through the European Patent Office.
